This program, directed by Neal Lindeman, M.D. focuses on diagnosing and confirming diagnoses of Mendelian genetic disorders, diseases of human development, infectious diseases, and malignancies, as well as assessing the natural history of those disorders.
Molecular Genetic Pathology is recognized as a subspecialty by the American Board of Medical Specialties (ABMS) [www.abms.org]. Residency training programs in this subspecialty are accredited by the American Council of Graduate Medical Education (ACGME) [www.acgme.org], are one year in duration, and available only to licensed clinical geneticists who are board certified by ABMG or diplomates of the American Board of Pathology.
The training program instructs molecular genetic pathologists in the principles, theory and technologies of molecular biology and molecular genetics. Upon graduation, molecular genetic pathologists can provide information about gene structure, function and alteration and apply laboratory techniques for diagnosis, treatment and prognosis for individuals with related disorders.
More information can be found at: http://www.brighamandwomens.org/Departments_and_Services/pathology/Medical/MolecGeneticPathology.aspx